Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Advances in Therapy

• Publication date

  2018-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12325-018-0782-1PMID 30219991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry.

  2016cited by this paper
• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

  2014cited by this paper
• Atrial Fibrillation, Stroke, and Anticoagulation in Medicare Beneficiaries: Trends by Age, Sex, and Race, 1992–2010

  2014cited by this paper
• Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study.

  2013cited by this paper
• Edoxaban versus warfarin in patients with atrial fibrillation.

  2013cited by this paper
• Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation Among Patients Hospitalized With Heart Failure

  2013cited by this paper
• Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007

  2012cited by this paper
• Apixaban versus warfarin in patients with atrial fibrillation.

  2011cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States

  2011cited by this paper
• Dabigatran versus warfarin in patients with atrial fibrillation.

  2009cited by this paper
• Cost of atrial fibrillation in United States managed care organizations

  2009cited by this paper
• Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

  2009cited by this paper
• Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation

  2008cited by this paper
• Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

  2007cited by this paper
• Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation.

  2007cited by this paper
• Atrial Fibrillation and Stroke in the General Medicare Population: A 10-Year Perspective (1992 to 2002)

  2006cited by this paper
• Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation

  2006cited by this paper
• Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

  2006cited by this paper
• Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial.

  2006cited by this paper
• Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention

  2003cited by this paper
• Racial variation in initial stroke severity.

  2000cited by this paper
• Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

  1998cited by this paper

• Gender Differences in Patients with Atrial Fibrillation Receiving Oral Anticoagulants

  2024cites this paper
• Atrial Fibrillation, No Matter How Defined, Is a Cost Burden: Insights to Drive Population Health.

  2024cites this paper
• Differences in quality of anticoagulation care delivery according to ethnoracial group in the United States: A scoping review

  2024cites this paper
• Race, ethnicity, sex, and socioeconomic disparities in anticoagulation for atrial fibrillation: A narrative review of contemporary literature.

  2023cites this paper
• Chronic oral anticoagluation and risk of prostate cancer: Evidence of detection bias

  2020cites this paper